GlassScriptPhysician profile
Alex C Mostone
NPI 1619504453
$7,052.88
in general payments reported to CMS, 2019-2025
32 companies · $2,718 in 2025
The $2,718 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.79 · 2022: $584 · 2023: $1,531 · 2024: $2,207 · 2025: $2,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,409 · Education: $46.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,409.46 |
| Education | $46.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,050.26 | 2022-2025 | Erleada, Akeega |
| Antares Pharma, INC. | $820.57 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Dendreon Pharmaceuticals LLC | $593.78 | 2024-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $487.81 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $445.36 | 2024-2025 | Xiaflex, Aveed |
| Tolmar, INC. | $415.39 | 2023-2025 | Jatenzo, Eligard |
| Astellas Pharma US INC | $370.23 | 2022-2025 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $330.61 | 2024-2025 | |
| Abbvie INC. | $319.77 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $277.69 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $250.58 | 2023-2024 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $225.62 | 2022-2025 | Givlaari |
| Axonics, INC. | $171.63 | 2022-2023 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $153.38 | 2023-2025 | Myrisk, Prolaris |
| Teleflex LLC | $151.94 | 2022-2024 | Urolift |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $127.99 | 2023 | |
| Progenics Pharmaceuticals, INC. | $120.97 | 2022-2025 | Pylarify |
| Abc Home Medical Supply, INC. | $90.71 | 2024-2025 | |
| Medtronic, INC. | $90.49 | 2023-2025 | Interstim |
| Merck Sharp & Dohme LLC | $89.68 | 2022-2025 | Keytruda, Lynparza |
| Olympus America INC. | $75.24 | 2025 | Itind System |
| Hollister Incorporated | $57.71 | 2024 | Vapro Plus Pocket |
| Coloplast Corp | $57.70 | 2024-2025 | |
| Convatec INC. | $46.41 | 2023 | |
| Laborie Medical Technologies Corp. | $37.93 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $34.72 | 2021-2022 | |
| Immunitybio, INC. | $31.24 | 2025 | |
| Calyxo, INC. | $30.54 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $28.45 | 2024 | Cure Catheter |
| Vertex Pharmaceuticals Incorporated | $28.00 | 2025 | |
| Tempus Ai, INC | $23.16 | 2024 | Xt Cdx |
| Kowa Pharmaceuticals America, INC. | $17.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Mostone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.